|
| 36723668 | Association between adjuvant therapy and survival in colorectal cancer patients according to metabolic Warburg-subtypes. | J Cancer Res Clin Oncol | 2023 |
| 35785488 | Association between mutational subgroups, Warburg-subtypes, and survival in patients with colorectal cancer. | Cancer Med | 2023 |
| 37033104 | Histologic reâ¿¿evaluation of a populationâ¿¿based series of renal cell carcinomas from The Netherlands Cohort Study according to the 2022 ISUP/WHO classification. | Oncol Lett | 2023 |
| 34791830 | Expression of proteins associated with the Warburg-effect and survival in colorectal cancer. | J Pathol Clin Res | 2022 |
| 35444164 | Evaluation of a seven gene mutational profile as a prognostic factor in a population-based study of clear cell renal cell carcinoma. | Sci Rep | 2022 |
| 35584320 | Lessons From a Systematic Literature Search on Diagnostic DNA Methylation Biomarkers for Colorectal Cancer: How to Increase Research Value and Decrease Research Waste? | Clin Transl Gastroenterol | 2022 |
| 35477541 | Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers. | Clin Epigenetics | 2022 |
| 35546360 | Energy balance-related factors and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status. | J Cancer Res Clin Oncol | 2022 |
| 36177801 | Energy balance-related factors in childhood and adolescence and risk of colorectal cancer based on KRAS, PIK3CA, and BRAF mutations and MMR status. | Mol Carcinog | 2022 |
| 35064924 | Energy balance-related factors in childhood and adolescence and risk of colorectal cancer expressing different levels of proteins involved in the Warburg-effect. | Int J Cancer | 2022 |
| 34933957 | Energy Balance-Related Factors and Risk of Colorectal Cancer Expressing Different Levels of Proteins Involved in the Warburg Effect. | Cancer Epidemiol Biomarkers Prev | 2022 |
| 31402218 | Diagnostic DNA Methylation Biomarkers for Renal Cell Carcinoma: A Systematic Review. | Eur Urol Oncol | 2021 |
| 33890711 | Loss of enteric neuronal Ndrg4 promotes colorectal cancer via increased release of Nid1 and Fbln2. | EMBO Rep | 2021 |
| 33858496 | Identification of DNA methylation markers for early detection of CRC indicates a role for nervous system-related genes in CRC. | Clin Epigenetics | 2021 |
| 34272264 | Validity and Reproducibility of Immunohistochemical Scoring by Trained Non-Pathologists on Tissue Microarrays. | Cancer Epidemiol Biomarkers Prev | 2021 |
| 33947447 | Development of a prognostic risk model for clear cell renal cell carcinoma by systematic evaluation of DNA methylation markers. | Clin Epigenetics | 2021 |
| 32218259 | Biobanking in Molecular Biomarker Research for the Early Detection of Cancer. | Cancers (Basel) | 2020 |
| 32005275 | Prognostic DNA methylation markers for hormone receptor breast cancer: a systematic review. | Breast Cancer Res | 2020 |
| 31641693 | The trans-DATA study: aims and design of a translational breast cancer prognostic marker identification study. | Diagn Progn Res | 2019 |
| 29564023 | Prognostic DNA methylation markers for sporadic colorectal cancer: a systematic review. | Clin Epigenetics | 2018 |
| 29867106 | Epigenetics in renal cell cancer: mechanisms and clinical applications. | Nat Rev Urol | 2018 |
| 29666440 | Analysis of DNA methylation in cancer: location revisited. | Nat Rev Clin Oncol | 2018 |
| 29713045 | Author Correction: Analysis of DNA methylation in cancer: location revisited. | Nat Rev Clin Oncol | 2018 |
| 26774327 | Decision support systems for personalized and participative radiation oncology. | Adv Drug Deliv Rev | 2017 |
| 28803494 | Prognostic DNA methylation markers for renal cell carcinoma: a systematic review. | Epigenomics | 2017 |
| 28012793 | PET imaging of zirconium-89 labelled cetuximab: A phase I trial in patients with head and neck and lung cancer. | Radiother Oncol | 2017 |
| 27756787 | A Four-Gene Promoter Methylation Marker Panel Consisting of <i>GREM1, NEURL, LAD1,</i> and <i>NEFH</i> Predicts Survival of Clear Cell Renal Cell Cancer Patients. | Clin Cancer Res | 2017 |
| 27118999 | Analysis of RET promoter CpG island methylation using methylation-specific PCR (MSP), pyrosequencing, and methylation-sensitive high-resolution melting (MS-HRM): impact on stage II colon cancer patient outcome. | Clin Epigenetics | 2016 |
| 25538088 | Spectrin repeat containing nuclear envelope 1 and forkhead box protein E1 are promising markers for the detection of colorectal cancer in blood. | Cancer Prev Res (Phila) | 2015 |
| 26395528 | Modern clinical research: How rapid learning health care and cohort multiple randomised clinical trials complement traditional evidence based medicine. | Acta Oncol | 2015 |
| 24375389 | Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine. | Cancer Metastasis Rev | 2014 |
| 24928946 | CHFR promoter methylation indicates poor prognosis in stage II microsatellite stable colorectal cancer. | Clin Cancer Res | 2014 |
| 24861629 | Epigenetics in radiotherapy: where are we heading? | Radiother Oncol | 2014 |
| 24560444 | Promoter CpG island methylation of RET predicts poor prognosis in stage II colorectal cancer patients. | Mol Oncol | 2014 |
| 23532114 | A novel classification of colorectal tumors based on microsatellite instability, the CpG island methylator phenotype and chromosomal instability: implications for prognosis. | Ann Oncol | 2013 |
| 24044794 | Cardiac comorbidity is an independent risk factor for radiation-induced lung toxicity in lung cancer patients. | Radiother Oncol | 2013 |
| 22056543 | The CpG island methylator phenotype in colorectal cancer: progress and problems. | Biochim Biophys Acta | 2012 |
| 22449189 | Promoter CpG island methylation markers in colorectal cancer: the road ahead. | Epigenomics | 2012 |
| 21278247 | Genomic and epigenomic integration identifies a prognostic signature in colon cancer. | Clin Cancer Res | 2011 |
| 21994416 | A let-7 microRNA SNP in the KRAS 3'UTR is prognostic in early-stage colorectal cancer. | Clin Cancer Res | 2011 |
| 22135196 | Participation in colorectal cancer screening trials after first-time invitation: a systematic review. | Endoscopy | 2011 |
| 21707706 | Modified UroVysion scoring criteria increase the urothelial carcinoma detection rate in cases of equivocal urinary cytology. | Histopathology | 2011 |
| 21102419 | Loss of SerpinA5 protein expression is associated with advanced-stage serous ovarian tumors. | Mod Pathol | 2011 |
| 21220596 | Colorectal cancer epigenetics: complex simplicity. | J Clin Oncol | 2011 |
| 20042676 | Prognostic significance of Gremlin1 (GREM1) promoter CpG island hypermethylation in clear cell renal cell carcinoma. | Am J Pathol | 2010 |
| 20382342 | Body mass index and von Hippel-Lindau gene mutations in clear-cell renal cancer: Results of the Netherlands Cohort Study on diet and cancer. | Ann Epidemiol | 2010 |
| 19509152 | GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. | Clin Cancer Res | 2009 |
| 19759417 | Different angiogenic potential in low and high grade sporadic clear cell renal cell carcinoma is not related to alterations in the von Hippel-Lindau gene. | Cell Oncol | 2009 |
| 19435926 | Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. | Cancer Res | 2009 |
| 19535783 | N-Myc downstream-regulated gene 4 (NDRG4): a candidate tumor suppressor gene and potential biomarker for colorectal cancer. | J Natl Cancer Inst | 2009 |